QX-4533 / QuantX Biosciences - LARVOL DELTA

Phase 1 Study of QX-4533 in Healthy Volunteers and Patients With Moderate-to-Severe Atopic Dermatitis (clinicaltrials.gov) - P1 | N=84 | Recruiting | Sponsor: QuantX Biosciences, Inc. | Not yet recruiting ➔ Recruiting

Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

Phase 1 Study of QX-4533 in Healthy Volunteers and Patients With Moderate-to-Severe Atopic Dermatitis (clinicaltrials.gov) - P1 | N=84 | Not yet recruiting | Sponsor: QuantX Biosciences, Inc.

New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology